Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance.
Flisiak R, Zarębska-Michaluk D, Rogalska M, Kryńska JA, Kowalska J, Dutkiewicz E, Dobrowolska K, Jaroszewicz J, Moniuszko-Malinowska A, Rorat M, Podlasin R, Tronina O, Rzymski P.
Flisiak R, et al. Among authors: dobrowolska k.
Pharmacol Rep. 2022 Dec;74(6):1279-1285. doi: 10.1007/s43440-022-00408-6. Epub 2022 Aug 24.
Pharmacol Rep. 2022.
PMID: 36001284
Free PMC article.